Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$18.54
+3.95%
Mkt Cap $6.55B
Analyst Ratings
Buy
8
Hold
3
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
Implied Upside
-5.6%
Consensus $17.50 vs current $18.54
NASDAQ·Healthcare·Biotechnology
$18.54
+3.95%
Mkt Cap $6.55B
Buy
8
Hold
3
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
-5.6%
Consensus $17.50 vs current $18.54